Press Releases
Announces Appointment Of Cathy Steiner To Board Of Directors
OAKVILLE, ON, Oct. 8, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today the voting results for the election of directors at its Annual Meeting of Shareholders held earlier today.
A total of 12,068,167 common shares representing 44.62% of the Company's issued and outstanding common shares as of the record date for the meeting, were represented by shareholders present in person or by proxy at the meeting. Shareholders voted in favour of all items of business put forth at the meeting. The votes for the election of directors were as follows:
Nominee | % of Shares Voted For | % of Shares Withheld |
Arthur Deboeck | 92.10% | 7.90% |
Christian Godin | 98.66% | 1.34% |
Craig Mull | 92.11% | 7.89% |
Dr. John Mull | 92.13% | 7.87% |
Cathy Steiner | 99.75% | 0.25% |
Harold Wolkin | 98.68% | 1.32% |
"We are pleased to welcome Cathy Steiner to Cipher's Board," said Mr. Craig Mull, Chairman and Interim CEO of Cipher Pharmaceuticals. "Ms. Steiner has over 20 years experience as an investment banker and strategic advisor working with healthcare companies. Cathy joins Cipher at an exciting time and we believe her expertise will be invaluable as we continue to right size the business and look for the right opportunities for growth."
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
